His scientific interests lie mostly in Neuroscience, Schizophrenia, Psychosis, Stimulus and Event-related potential. His study in Auditory cortex, Cognition, Visual processing, Brain mapping and Visual system is done as part of Neuroscience. His Brain mapping research incorporates elements of Schizophrenia and Electroencephalography.
His work deals with themes such as NMDA receptor, Sensory processing and Pharmacology, which intersect with Schizophrenia. Daniel C. Javitt combines subjects such as Mismatch negativity, Internal medicine and Cognitive disorder with his study of Psychosis. His Stimulus research is multidisciplinary, incorporating perspectives in Evoked potential, Visual perception, Cognitive psychology and Auditory perception.
Daniel C. Javitt mainly investigates Schizophrenia, Neuroscience, Psychosis, Cognitive psychology and Audiology. His research in Schizophrenia tackles topics such as Internal medicine which are related to areas like Endocrinology. Neuroscience is closely attributed to NMDA receptor in his work.
His work carried out in the field of Psychosis brings together such families of science as Brain mapping and Antipsychotic. Daniel C. Javitt studied Cognitive psychology and Perception that intersect with Prosody. The various areas that Daniel C. Javitt examines in his Audiology study include Developmental psychology and Mismatch negativity.
Daniel C. Javitt mostly deals with Schizophrenia, Neuroscience, Audiology, Mismatch negativity and Cognition. His Schizophrenia research includes themes of Cognitive psychology, Psychosis, Internal medicine and Social cognition. His Cognitive psychology research includes elements of Contrast and Auditory cortex.
His Neuroscience study integrates concerns from other disciplines, such as NMDA receptor and Schizophrenia. His study on Audiology also encompasses disciplines like
The scientist’s investigation covers issues in Schizophrenia, Neuroscience, Mismatch negativity, NMDA receptor and Audiology. His Schizophrenia research is multidisciplinary, incorporating perspectives in Cognitive psychology, Cognition, Internal medicine and Electroencephalography. His Neuroscience study typically links adjacent topics like Psychosis.
His Mismatch negativity research integrates issues from Alpha and Bitopertin. His studies deal with areas such as Agonist, Glycine transport, Dopamine and Dorsolateral prefrontal cortex as well as NMDA receptor. He works mostly in the field of Audiology, limiting it down to concerns involving Developmental psychology and, occasionally, Dissociation, Schizophrenia spectrum and Emotion recognition.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recent advances in the phencyclidine model of schizophrenia.
Daniel C. Javitt;Stephen R. Zukin.
American Journal of Psychiatry (1991)
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
John E. Lisman;Joseph T. Coyle;Robert W. Green;Daniel C. Javitt.
Trends in Neurosciences (2008)
Multisensory auditory-visual interactions during early sensory processing in humans: a high-density electrical mapping study.
Sophie Molholm;Walter Ritter;Walter Ritter;Micah M Murray;Daniel C Javitt;Daniel C Javitt.
Cognitive Brain Research (2002)
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
Bita Moghaddam;Daniel Javitt.
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia
Daniel C. Javitt;Mitchell Steinschneider;Charles E. Schroeder;Joseph C. Arezzo.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Do You See What I Am Saying? Exploring Visual Enhancement of Speech Comprehension in Noisy Environments
Lars A. Ross;Dave Saint-Amour;Victoria M. Leavitt;Victoria M. Leavitt;Daniel C. Javitt;Daniel C. Javitt.
Cerebral Cortex (2006)
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Daniel C. Javitt.
International Review of Neurobiology (2007)
Glutamate as a therapeutic target in psychiatric disorders.
D C Javitt.
Molecular Psychiatry (2004)
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia
Daniel Umbricht;Liselotte Schmid;Rene Koller;Franz X. Vollenweider.
Archives of General Psychiatry (2000)
The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry.
Kate Brody Nooner;Kate Brody Nooner;Stanley J. Colcombe;Russell H. Tobe;Maarten Mennes;Maarten Mennes.
Frontiers in Neuroscience (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: